Liver Diseases Therapeutics Market Growth Is Driven By Wide R&D Practices By Industry Players Till 2022

The Liver Diseases Therapeutics Market had value over USD 7,498.0 million in 2014. The major driving factors are increasing numbers of liver diseases like hepatocellular carcinoma and vast unexploited need of patients with these types of diseases. In addition, increasing geriatric population globally is estimated to augment the market demand in the future period.

Huge expenditure by biotechnology and pharmaceutical industries on R&D and availability of sturdy pipeline are the major expected boosting factors for the growth of liver diseases therapeutics market in future period. Governments’ and big companies’ vaccination program are creating awareness about the illness and prevention is boosting the growth of the market.

The market is bifurcated into products and regions. New products are rapidly being launched boosting the market growth. The growth of the market is boosted by the strategic alliances, joint venture between the major players, and growing awareness of healthcare in the upcoming nations.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/liver-diseases-therapeutics-market

Nonetheless, risks and side effects linked with existing medication & stringent FDA and other norms approved by the government along with accessibility of varying treatment measures perform as barriers to the industry. The market was dominated by the antiviral drug sector with a value over USD 2631 million in revenue terms in 2014.

Rising population with liver diseases due to increasing number of alcohol consumers is estimated to boost the market share. Alternatively, the antiviral drug is estimated to observer profitable raise of over 8.8% from 2015 to 2022. This is due to the occurrence of drugs in the pipeline.

The market is estimated to be at over USD 12095.0 million by 2022. This is going to happen due to the increasing geriatric population, rising liver ailments like hepatocellular and hepatitis carcinoma along with high requirement for programs on vaccination in developing nations and high spending on growing healthcare in the developed nations.

North America is dominating the global market due to academic and research institutions performing studies related to medical trials. North America had more than 39% share of the global market in 2014 and is anticipated to carry on leading till 2022. Asia Pacific had share over USD 1615.5 million in 2014 and is estimated at CAGR over 8.5% in the future.

Few of the major industries are Abbott Laboratories, Gilead Sciences, Astellas Pharma Inc., GlaxoSmithKline plc, Bristol-Mayers Squibb, and Merck & Co., Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Lung Cancer Diagnostics Market Is Going To Surpass $3.64 Billion By 2024: Grand View Research, Inc.

The global Lung Cancer Diagnostics Market is expected to reach USD 3,644.6 million by 2024, according to a new report by Grand View Research Inc. The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. 

Various biomarkers are present in the research pipeline. For instance, in November 2015, Epigenomics AG announced the launch of a new blood-based test using DNA methylation biomarkers, the development of which is underway. The initial results of this test revealed a promising outcome in the early diagnosis of lung cancer. 

Furthermore, various awareness programs focusing on lung cancer and its associated symptoms are initiated in an attempt to elevate the screening and diagnosis rates inindividuals at a high risk of developing lung malignancies. For instance, November is considered as a lung cancer awareness month across the UK, which is supported by the Roy Castle Lung Cancer Foundation. 

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/lung-cancer-diagnostics-market

Further key findings from the study suggest:

• The small cell lung cancer segment accounted for around 15% market share in 2015. This is an aggressive subtype of the lung malignancies, which has proven to be fatal within a short period of time if left undiagnosed.
• Non-small cell lung cancer was identified as the largest segment in 2015 with revenue of over USD 1,300.0 million. This is majorly due to the availability of novel lung cancer diagnostics that facilitate the detection of large tumor growths.
• The imaging tests segment was identified as the largest revenue generating segment in 2015 with a market share of around 50%. Major factors responsible for the large market share include the frequent use of various imaging techniques such as CT scan, X-ray, and MRI in the detection of lung malignancies coupled with the increased availability of the diagnostic tools.
• The molecular testing segment is expected to grow at a profitable rate of around 10% over the forecast period. The introduction of novel molecular testing techniques coupled with the increasing number of investments to support the research and development efforts for the development of biomarker-based molecular testing in lung cancer detection is expected to foster the demand of this segment over the forecast period.
• In 2015, North America accounted for the largest revenue share of over 30% majorly due to supportive government policies in the region coupled with the availability of technology-enabled lung cancer diagnostics
• Asia Pacific region is expected to reach a revenue share of over 28% by 2024. Major factors responsible for the growth include the constantly improving healthcare infrastructure, the growing awareness of the disease symptoms, and a wide base of unmet clinical needs in the developing countries in the region.
• Major players of this market include bioMérieux, Roche Diagnostics, Qiagen N.V., Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, Janssen, AstraZeneca plc, and Sanofi S.A.
• Novel product launches in the lung cancer diagnostics product portfolio is one of the major strategic initiatives adopted by the market players. For instance, Orion genomics is involved in the development of novel biomarkers for lung cancer diagnosis. Allegro Diagnostics is involved in the development and commercialization of pulmonary genomics-based lung cancer diagnostics. 

 Grand View Research has segmented the global lung cancer diagnostics market on the basis of type, test, and region:

Global Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2016 - 2024)

• Small Cell Lung Cancer
• Non-small Cell Lung Cancer

Global Lung Cancer Diagnostics Test Outlook (Revenue, USD Million, 2016 - 2024)

• Imaging Test
• Biopsy
• Sputum Cytology
• Molecular Test
• Others

Lung Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Russia
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-lung-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

U.S. Frozen Food Market Size Would Be $72.98 Billion By 2024: Grand View Research, Inc.

The U.S. Frozen Food Market is expected to reach USD 72.98 billion by 2024, according to a new report by Grand View Research, Inc. Greater economic participation from all segments of the U.S. society has resulted in hectic work schedules thus causing a change in lifestyles. Frozen food provides convenience thus catering to this shifting trend. 

Frozen foods are easy to carry, cook and consume. They do not require much preparation before consumption. They come in pre-portioned and pre-measured quantities which reduce waste. Thus, they limit the time needed for cooking and this trend is expected to benefit the U.S. market over the forecast period. 

Fruits & vegetables are frozen at the time of their ripeness. Advancements in freezing technology have enabled to lock in all the nutrients in the products. Furthermore, competitive pricing has allowed frozen foods to be available in comparatively fewer prices. All these inherent benefits are expected to drive the overall market over the next eight years. 

Government regulations coupled with health concerns are expected to restrain the market growth. To overcome this restraint, companies impose strict quality checks on their raw material sourcing processes. Also, companies have reduced the content of harmful substances such as trans fats in frozen food. 

There have been recent advancements such as the creation of new formulations that remove allergens like dairy, soy, and wheat, the introduction of a wide range of ethnic, and ingredients to suit changing palates and innovations in packaging are expected to impact the overall industry growth positively.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/us-frozen-food-market

Further key findings from the report suggest:

• Frozen potatoes are presumed to be the fastest growing product segment growing at a CAGR of 4.9% over the forecast period. Advantages such as less waste, low price and ease of usage are expected to drive the market growth
• Frozen fruits & vegetable segment is presumed to grow at a CAGR of 4.5% from 2016 to 2024. High nutritional value, all season availability and competitive pricing are the attributed factors for this growth
• Frozen ready meals accounted for more than 35% in 2015 and are expected to occupy a major share over the forecast period. Availability of staple ready meals, product differentiation and ease of usage are the factors expected to drive this growth
• The industry is fragmented in nature with the presence of both regional and international market participants. Companies are focusing on manufacturing process optimization to reduce wastage. Innovation is a key market characteristic
• McCain, Inn Foods, ConAgra Foods, Pinnacle Foods Groups, General Mills Inc., Bellisio Foods, Jeanie Marshall Foods Inc., and Goya Foods are some of the major market participants.

Grand View Research has segmented the U.S. frozen food market on the basis of product:

U.S. Frozen Food Market Product Outlook (Revenue, USD Million, 2014 - 2024)

• Frozen fruits & vegetables
• Frozen potatoes
• Frozen ready meals
• Frozen meat
• Frozen fish/seafood
• Frozen soup
• Others

Browse Press Release of this Report: www.grandviewresearch.com/press-release/us-frozen-food-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bioactive Wound Care Market Is Poised To Reach $11.9 Billion By 2024: Grand View Research, Inc.

The global Bioactive Wound Care Market is expected to reach USD 11.9 billion by 2024, according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians’ advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/bioactive-wound-care-market

Further key findings from the study suggest:

• The moist wound care products segment held a lucrative share of more than 50.0% in 2015. The ability of these products to create a supportive moist environment, which expedites the healing process, is a notable feature of these products. Moist wound care products include foams, films, alginates, hydrocolloids, and hydrogels.
• The antimicrobials segment, comprising products impregnated with silver and non-silver ingredients, is anticipated to witness profitable growth over the forecast period. These products are cost efficient with lower chances of developing resistance to antimicrobial products.
• The segment of active wound care products, likewise, is anticipated to exhibit a significant growth rate in the coming 8 years. Recently, the U.S. Food and Drug Administration approved a couple of biomaterials, Dermagraft, and Alpigraph, for management of skin-related injuries. The ability of these products to mimic biological properties is a key advantage that enables a faster healing process.
• North America contributed with a share of more than 30.0% of the global bioactive wound care market. Presence of major players, streamlined regulations, and favorable reimbursement policies are some of the key contributing factors responsible for the growth of this region.
• Asia Pacific with its huge potential is anticipated to witness considerable growth over the forecast period. The presence of a huge untapped population, stirring economic developments in this region, and consistent efforts undertaken to improve the healthcare infrastructure are the key growth drivers.
• The key players in this industry include Smiths & Nephew, Mölnlycke Health Care, ConvaTec, Inc., Paul Hartmann AG, Organogenesis, Inc., Systagenix Wound Management Ltd., 3M Healthcare Ltd., Medtronic, Covalon Technologies Ltd., BSN Medical, and Medline Industries, Inc.
• The strategic endeavors undertaken by the leading players in the industry include new product launches, collaborations with government bodies, and R&D investments.
• In July 2015, Smith & Nephew acquired DeOst LLC and DeLLC, part of the DeOST group, which is a manufacturer of medical devices in Russia. This acquisition is expected to help companies expand their global footprints.

Grand View Research has segmented the global bioactive wound care market on the basis of product and region:

Global Bioactive Wound Care Market, By Product (USD Million), 2013 - 2024

• Moist Wound Care
  • Foams
  • Films
  • Alginates
  • Hydrocolloids
  • Hydrogels
• Antimicrobial Wound Care
  • Silver-based
  • Non-silver-based
• Active Wound Care
  • Biomaterials
  • Skin substituents

Bioactive Wound Care Market, By Region (USD Million), 2013 - 2024

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

Browse Full Press Release of This Report: www.grandviewresearch.com/press-release/global-bioactive-wound-care-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bioresorbable Polymer Market Size Would Be Around Of $2.26 Billion by 2025: Grand View Research, Inc.

The global Bioresorbable Polymer Market is anticipated to reach USD 2.26 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand in the medical sector, owing to its hydrolytically degrading property in the body is projected to increase the global market growth. 

The increasing health awareness, improving healthcare facilities worldwide and growing surgery procedures across the globe will have a positive impact on the bioresorbable polymers industry growth in the overcoming years.

The increasing product demand for drug delivery application is another key factor for market development over the forecast period. The harmless decomposition and its chemically neutral nature in the body make them suitable for drug delivery segment.

The PLA-based product demand exceeded 89 tons in 2015, which is projected to remain as the largest and fastest growing segment over the upcoming years. The PLA market is growing dramatically in the pharmaceutical sector owing to its distinctive feature of being biodegradable and biocompatible.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/bioresorbable-polymers-market

  

Further Key Findings from the Study Suggest:

• The global bioresorbable polymers demand was over 298 tons in 2015 and is expected to grow at an estimated CAGR of 14.3% over the projected period
• The PCL-based product market accounted for over 13% of the total revenue in 2015
• Orthopedics was the leading application segment with demand exceeding 45% in 2015
• The bioresorbable polymer market in drug delivery application is estimated to have the highest growth at a CAGR of over 14% from 2016 to 2025
• The U.S. polyglycolic acid product market generated revenue worth of USD 31.5 million in 2015 and is expected to reach a total revenue of over USD 110 million by 2025
• Polysaccharides demand in Europe is estimated to exceed a total revenue of USD 470 million by the end of forecast period
• Factors such as changing consumption patterns, technological advancements, and rising government initiatives, are anticipated to influence the market in the overcoming years
• Influential companies operating in this market include Carbion NV, Evonik Industries AG, Poly-Med, Inc., Foster Corporation and KLS Martin Group
• Evonik and Carbion dominated the global market together accounting for over 50% of the total revenue in 2015

Grand View Research has segmented the bioresorbable polymer market on the basis of product, application and region:

Bioresorbable Polymers Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Polysaccharides
• Proteins
• Polylactic acid
• Polyglycolic acid
• Polycaprolactone
• Others

Bioresorbable Polymers Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Drug Delivery
• Orthopedics
• Others

Bioresorbable Polymers Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Middle East and Africa
• Central & South America

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-bioresorbable-polymers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Environmental Health And Safety Market Is Poised To Reach $96.18 Billion By 2025: Grand View Research, Inc.

The global Environmental Health And Safety Market is expected to reach USD 96.18 billion by 2025, according to a new report by Grand View Research, Inc. The increasing number of regulations imposed by environmental protection and governmental agencies worldwide is expected to be one of the major factors driving demand during the forecast period.

Economic slowdown in several parts of the globe has led to significant corporate restructuring, plant closures, and mothballing. These business decisions are, however, made taking into consideration the various environmental challenges posed by these decisions. There is an increasing need for minimizing environmental liabilities and eliminating long-term risks.

These factors have led several agencies and governmental organizations to impose stringent compliance requirements across industries, with regards to ecological conservation, and safety and health of personnel. This trend is mainly being witnessed in the North American region, followed by Asia Pacific. 

There are various safety hazards in core industries such as energy & mining, construction, etc., which pose several challenges in the form of ecological contamination, injuries to personnel, and personnel deaths. For instance, the oil & gas industry globally is faced with hazards such as explosions, fires, vehicle accidents, and caught-in or caught-between accidents caused by moving equipment, high-pressure lines, and falling equipment.

As a result of the aforementioned factors, companies across core industries such as chemicals, petrochemicals, energy & mining, construction, manufacturing, healthcare, and telecommunications are being increasingly pressurized to comply with the various regulations put forth by governmental agencies to ensure environmental and worker health and safety. 

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/environmental-health-and-safety-market

  

Further key findings from the report suggest

• The industrial application segment accounted for over 55% of the overall market revenue in 2015, owing to the growing compliance requirements in key industries such as oil & gas, construction, manufacturing, and chemicals
• The demand for the service in energy & mining is expected to grow at a CAGR of over 8% from 2016 to 2025, owing to high regulatory compliance pertaining to work place safety in the industry
• The U.S. is the largest market for EHS as of 2015, and is expected to continue its dominance through the forecast period, projected to grow at a CAGR of over 8.5% from 2016 to 2025
• The growth of the oil & gas industry in the country, along with the rapid recovery of the construction and manufacturing industries, is expected to increase the demand for EHS solutions in the U.S. during the forecast period
• Key participants in the industry, such as HS&E Group, AECOM, EHS Data Ltd., and RPS Group are focusing on satisfying stakeholder expectations, preservation on brand value, and efficient EHS compliance, thereby moving towards centralized EHS management models

Grand View Research has segmented the global environmental health and safety market on the basis of product, application, end-use and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

• EHS Software
• EHS Services

Application Outlook (Revenue, USD Million, 2014 - 2025)

• Medical & Pharmaceutical Waste Management
• Industrial Waste Management
• Waste Water Management

End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Chemical & Petrochemical
• Energy & Mining
• Healthcare
• Telecom & IT
• Construction
• Manufacturing
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-environmental-health-and-safety-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Facial Recognition Market In-depth Analysis and Segment Forecasts To 2020

Increasing security needs in government sectors for employee attendance and identification is expected to be a key driver for the facial recognition market over the forecast period. Facial recognition is a biometric technology which provides high-level security for public and private sectors. It takes into account selected facial features and compares them with a database to provide authorization.

Facial recognition system includes readers, software and related database for providing accuracy along with security. This technique is highly efficient for avoiding security breaches as compared to traditional authorization methods such as passwords and tokens etc.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/facial-recognition-market

Technology advancements such as cloud-based services and 3D recognition systems are further expected to fuel the overall market demand. Factors such as aging, makeup, plastic surgeries and other such medical procedures may affect the efficiency of these systems. Lack of accuracy and high implementation cost may hinder market growth over the next six years. Growing data security demand has spurred adoption across organizations, which is compounded by increased usage of personal devices as part of the BYOD policy in the IT sector.

Government initiatives such as UIDAI project in India and e-KTP project in Indonesia to generate electronic id generation of individuals are also expected to provide new opportunities for the facial recognition market in Asia Pacific.

About Grand View Research

 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com